CD47-SIRPα Checkpoint Inhibition Enhances Neutrophil-Mediated Killing of Dinutuximab-Opsonized Neuroblastoma Cells
出版年份 2021 全文链接
标题
CD47-SIRPα Checkpoint Inhibition Enhances Neutrophil-Mediated Killing of Dinutuximab-Opsonized Neuroblastoma Cells
作者
关键词
-
出版物
Cancers
Volume 13, Issue 17, Pages 4261
出版商
MDPI AG
发表日期
2021-08-25
DOI
10.3390/cancers13174261
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants
- (2021) Alessandra Dondero et al. Journal for ImmunoTherapy of Cancer
- Plasticity in Pro- and Anti-tumor Activity of Neutrophils: Shifting the Balance
- (2020) Charita Furumaya et al. Frontiers in Immunology
- The immune landscape of neuroblastoma: Challenges and opportunities for novel therapeutic strategies in pediatric oncology
- (2020) Judith Wienke et al. EUROPEAN JOURNAL OF CANCER
- First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers
- (2019) Branimir I. Sikic et al. JOURNAL OF CLINICAL ONCOLOGY
- The landscape of genomic alterations across childhood cancers
- (2018) Susanne N. Gröbner et al. NATURE
- Pediatric Cancer Immunotherapy: Opportunities and Challenges
- (2018) Mary Frances Wedekind et al. PEDIATRIC DRUGS
- Neutrophils Kill Antibody-Opsonized Cancer Cells by Trogoptosis
- (2018) Hanke L. Matlung et al. Cell Reports
- Dynamics of Transcription Regulation in Human Bone Marrow Myeloid Differentiation to Mature Blood Neutrophils
- (2018) Luigi Grassi et al. Cell Reports
- CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
- (2018) Ranjana Advani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer immunotherapy targeting the CD47/SIRPα axis
- (2017) Kipp Weiskopf EUROPEAN JOURNAL OF CANCER
- Neuroblastoma is composed of two super-enhancer-associated differentiation states
- (2017) Tim van Groningen et al. NATURE GENETICS
- Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries
- (2017) Valentina Boeva et al. NATURE GENETICS
- Expression of Disialoganglioside (GD2) in Neuroblastic Tumors: A Prognostic Value for Patients Treated With Anti-GD2 Immunotherapy
- (2017) Tatjana Terzic et al. PEDIATRIC AND DEVELOPMENTAL PATHOLOGY
- Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity
- (2017) Nan Guo Ring et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Replication Study: The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
- (2017) Stephen K Horrigan et al. eLife
- Regulation of neutrophil functions through inhibitory receptors: an emerging paradigm in health and disease
- (2016) Benoit Favier IMMUNOLOGICAL REVIEWS
- Neutrophils in cancer
- (2016) Louise W. Treffers et al. IMMUNOLOGICAL REVIEWS
- Lack of immunocytological GD2 expression on neuroblastoma cells in bone marrow at diagnosis, during treatment, and at recurrence*
- (2016) Roswitha Schumacher-Kuckelkorn et al. PEDIATRIC BLOOD & CANCER
- Immunoreceptors on neutrophils
- (2016) Dieke J. van Rees et al. SEMINARS IN IMMUNOLOGY
- Comparison of RNA-seq and microarray-based models for clinical endpoint prediction
- (2015) Wenqian Zhang et al. GENOME BIOLOGY
- Neutrophils mediate antibody-induced antitumor effects in mice
- (2013) M. Albanesi et al. BLOOD
- Newly-derived neuroblastoma cell lines propagated in serum-free media recapitulate the genotype and phenotype of primary neuroblastoma tumours
- (2013) Laurel T. Bate-Eya et al. EUROPEAN JOURNAL OF CANCER
- Increasing FcγRIIa affinity of an FcγRIII-optimized anti-EGFR antibody restores neutrophil-mediated cytotoxicity
- (2013) Stefanie Derer et al. mAbs
- Mutational heterogeneity in cancer and the search for new cancer-associated genes
- (2013) Michael S. Lawrence et al. NATURE
- Neutrophils as effector cells for antibody-based immunotherapy of cancer
- (2013) Marjolein van Egmond et al. SEMINARS IN CANCER BIOLOGY
- Development of an Fc-Enhanced Anti-B7-H3 Monoclonal Antibody with Potent Antitumor Activity
- (2012) D. Loo et al. CLINICAL CANCER RESEARCH
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
- (2012) S. B. Willingham et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD47-signal regulatory protein- (SIRP ) interactions form a barrier for antibody-mediated tumor cell destruction
- (2011) X. W. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Guidelines for Imaging and Staging of Neuroblastic Tumors: Consensus Report from the International Neuroblastoma Risk Group Project
- (2011) Hervé J. Brisse et al. RADIOLOGY
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
- (2010) Alice L. Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recent Advances in Neuroblastoma
- (2010) John M. Maris NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started